These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 22396802
1. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. Khan Z, Ahmad S, Joseph L, Chandy R. PLoS One; 2012; 7(3):e32952. PubMed ID: 22396802 [Abstract] [Full Text] [Related]
2. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. Ahmad S, Khan Z, Mokaddas E, Khan ZU. J Med Microbiol; 2004 Jul; 53(Pt 7):633-637. PubMed ID: 15184534 [Abstract] [Full Text] [Related]
3. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. PLoS One; 2017 Jul; 12(4):e0175269. PubMed ID: 28380072 [Abstract] [Full Text] [Related]
4. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Mycoses; 2005 Sep; 48(5):347-51. PubMed ID: 16115107 [Abstract] [Full Text] [Related]
5. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients. Fotedar R, Al Hedaithy SS. Mycoses; 2004 Apr; 47(3-4):150-5. PubMed ID: 15078432 [Abstract] [Full Text] [Related]
7. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. McCullough MJ, Clemons KV, Stevens DA. J Clin Microbiol; 1999 Feb; 37(2):417-21. PubMed ID: 9889231 [Abstract] [Full Text] [Related]
8. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study. Mokaddas E, Khan ZU, Ahmad S. Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881 [Abstract] [Full Text] [Related]
15. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait. Ahmad S, Mokaddas E, Al-Sweih N, Khan ZU. Med Princ Pract; 2005 May; 14 Suppl 1():77-83. PubMed ID: 16103717 [Abstract] [Full Text] [Related]
16. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. Jabra-Rizk MA, Falkler WA, Merz WG, Baqui AA, Kelley JI, Meiller TF. J Clin Microbiol; 2000 Jun; 38(6):2423-6. PubMed ID: 10835022 [Abstract] [Full Text] [Related]
17. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. BMC Infect Dis; 2012 Sep 25; 12():230. PubMed ID: 23009343 [Abstract] [Full Text] [Related]
18. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR. J Clin Microbiol; 1999 Mar 25; 37(3):870-2. PubMed ID: 9986880 [Abstract] [Full Text] [Related]